Hippocratic AI, a healthcare startup developing patient-facing AI agents, has raised $141 million in Series B funding, valuing the company at $1.64 billion.
The round was led by Kleiner Perkins, with participation from existing investors General Catalyst, Andreessen Horowitz (a16z), and Nvidia.
Tackling Healthcare Workforce Shortages
Founded less than two years ago, Hippocratic AI addresses the critical shortage of healthcare professionals by creating AI agents capable of handling non-diagnostic, patient-facing tasks. These include:
- Pre-operative procedures.
- Remote patient monitoring.
- Appointment preparation.
Unlike many healthcare AI startups focused on reducing administrative workloads, Hippocratic’s solutions prioritize enhancing patient care and accessibility.
Advertisement
Rapid Growth and Adoption
In 2024, Hippocratic AI secured contracts with 23 health systems and insurers, showcasing strong market adoption. The new funding will fuel:
- Product expansion into additional healthcare markets.
- International growth, bringing its AI solutions to global audiences.
Momentum in Funding
This latest round follows a $53 million funding round led by General Catalyst and a16z nine months earlier, as well as a $17 million investment from Nvidia five months ago.
The Bigger Picture
As healthcare systems face increasing pressure to meet patient needs, Hippocratic AI is leveraging cutting-edge technology to bridge gaps in care delivery. With substantial backing from leading investors, the company is well-positioned to redefine how AI can support healthcare professionals and patients alike.
